PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
22-Mar-2024 Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia AccessWire
22-Mar-2024 Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE AccessWire
22-Mar-2024 Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA; g Evolva Holding SA
22-Mar-2024 Biophytis presented its phase 3 protocol in the treatment of sarcopenia Biophytis
22-Mar-2024 Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA Evolva Holding SA
22-Mar-2024 Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE Relief Therapeutics Holding SA
22-Mar-2024 CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency CD Formulation
21-Mar-2024 Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference AccessWire
21-Mar-2024 Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 AccessWire
21-Mar-2024 Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results AccessWire
21-Mar-2024 Anti-Decubitus Dynamic Mattresses market Analysis, Size, Share, Growth, Trends Forecasts 2023-2030 Metastat Insight and Technologies Pvt. Ltd.,
21-Mar-2024 Accuryn Medical Announces Maclean Health FSS Contract Award AccessWire
21-Mar-2024 MEDICLIN invites you to the virtual press conference on the financial statements for the year 2023 MediClin AG
21-Mar-2024 Notice to Attend The Annual General Meeting in XVIVO Perfusion AB (PUBL) AccessWire
21-Mar-2024 ABB’s new SDe Series to boost plant reliability and efficiency with seamless automation system upgrade ABB
21-Mar-2024 EVERSANA Named AI Excellence Award Winner for Third Consecutive Year, Recognized in Company Category for 2024 EVERSANA
21-Mar-2024 OKYO Pharma to Host Key Opinion Leader Event to Discuss New and Comprehensive Data from Phase 2 Dry Eye Disease Trial OKYO Pharma
21-Mar-2024 Eisbach and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumors Eisbach
21-Mar-2024 Novartis expands its biopharmaceutical manufacturing site in Singapore Novartis
21-Mar-2024 Curve Therapeutics April 2024 Conference Attendance Curve Therapeutics